Abbott Labs (ABT) PT Lowered to $121 at Goldman Sachs
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $88.06 -0.4%
Rating Summary:
24 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Rating Summary:
24 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Join SI Premium – FREE
Goldman Sachs analyst David Roman lowered the price target on Abbott Labs (NYSE: ABT) to $121.00 (from $140.00) while maintaining a Conviction Buy rating.
You May Also Be Interested In
- Piper Sandler on Abbott Labs (ABT): 'A Name Worth Revisiting'
- nCino Inc. (NCNO) PT Raised to $17 at JPMorgan
- Devon Energy (DVN) PT Lowered to $67 at Wolfe Research: Activist Toms interest positive
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
